About: Remacemide

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Remacemide is a drug which acts as a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. Because remacemide has only a modest effect on seizure frequency and causes dizziness, it is no longer believed that remacemide will be an effective treatment for epilepsy. Although no such statement has been made about remacemide's potential for treating stroke, Huntington's, or Parkinson's, remacemide is no longer being developed for these conditions.

Property	Value
dbo:abstract	Remacemide is a drug which acts as a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. Because remacemide has only a modest effect on seizure frequency and causes dizziness, it is no longer believed that remacemide will be an effective treatment for epilepsy. Although no such statement has been made about remacemide's potential for treating stroke, Huntington's, or Parkinson's, remacemide is no longer being developed for these conditions. Remacemide is also known as remacemide hydrochloride, (±)-2-amino-N-(1-methyl-1,2-diphenylethyl)-acetamide hydrochloride, or FPL 12924AA. (en)
dbo:alternativeName	Ecovia (en)
dbo:casNumber	128298-28-2
dbo:fdaUniiCode	EH6763C1IC
dbo:pubchem	60511
dbo:thumbnail	wiki-commons:Special:FilePath/Remacemide.svg?width=300
dbo:wikiPageExternalLink	http://pharmalicensing.com/public/articles/view/1053089151_3ec4dd7f9a2e3/big-pharma-licensing-strategies http://www.stanford.edu/group/hopes/cgi-bin/wordpress/2010/06/remacemide/
dbo:wikiPageID	18587598 (xsd:integer)
dbo:wikiPageLength	29378 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1117617699 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Carbamazepine dbr:Potency_(pharmacology) dbr:Electroencephalography dbr:Epilepsy dbr:New_Drug_Application dbr:Metabolite dbr:Noncompetitive_antagonist dbr:Anticonvulsant dbr:Huntington's_disease dbr:Pharmaceutical_drug dbr:Remacemide dbr:Research_and_Development dbr:Research_and_development dbr:License dbr:Ligand_(biochemistry) dbr:Racemic_mixture dbc:Acetamides dbc:NMDA_receptor_antagonists dbr:Oral_administration dbr:Orphan_drug dbr:Neuropathic_pain dbr:Ephenidine dbr:Crystal dbr:Lefetamine dbr:MT-45 dbr:Chirality_(chemistry) dbr:Clinical_trial dbr:Committee_for_Medicinal_Products_for_Human_Use dbr:Common_carotid_artery dbr:Zeneca dbr:Clinical_trials dbr:Pharmaceutical_industry dbr:Prodrug dbr:Suspension_(chemistry) dbr:Therapeutic_index dbr:Median_toxic_dose dbr:Ion_channel dbr:AD-1211 dbc:Sodium_channel_blockers dbr:Food_and_Drug_Administration dbr:Parkinson's_disease dbc:Diarylethylamines dbr:Isotopic_labeling dbr:Median_lethal_dose dbr:Pharmaceutical_formulation dbc:Amino_acid_derivatives dbc:Dissociative_drugs dbr:Astra_AB dbr:Ischemic_stroke dbr:AstraZeneca dbr:L-DOPA dbr:Lanicemine dbr:Blood–brain_barrier dbr:Stereoisomerism dbr:Diphenidine dbr:Dizziness dbr:Marketing_Authorization_Application dbr:Sodium dbr:Methoxphenidine dbr:Salt_(chemistry) dbr:Neuroprotection dbr:Experimental_drug dbr:IC50 dbr:Phases_of_clinical_research dbr:Excitotoxicity dbr:Fisons dbr:NMDA_receptor_antagonist dbr:NMDA_receptor dbr:Solubility dbr:Sodium_valproate dbr:MK801 dbr:NMDA_antagonist
dbp:atcPrefix	none (en)
dbp:c	17 (xsd:integer)
dbp:casNumber	128298 (xsd:integer)
dbp:chemspiderid	54551 (xsd:integer)
dbp:h	20 (xsd:integer)
dbp:iupacName	N-glycinamide (en)
dbp:n	2 (xsd:integer)
dbp:o	1 (xsd:integer)
dbp:pubchem	60511 (xsd:integer)
dbp:routesOfAdministration	dbr:Oral_administration
dbp:smiles	CCNCCN (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	YSGASDXSLKIKOD-UHFFFAOYSA-N (en)
dbp:synonyms	(-2-amino-N-[1,2-dipropan-2-yl]acetamide) PR 934-423 (en)
dbp:tradename	Ecovia (en)
dbp:unii	EH6763C1IC (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	448140837 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:width	150 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Chem_name dbt:Citation_needed dbt:Drugbox dbt:Hallucinogens dbt:Ionotropic_glutamate_receptor_modulators dbt:Reflist dbt:Short_description dbt:TOC_limit dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Stdinchicite dbt:Ion_channel_modulators
dcterms:subject	dbc:Acetamides dbc:NMDA_receptor_antagonists dbc:Sodium_channel_blockers dbc:Diarylethylamines dbc:Amino_acid_derivatives dbc:Dissociative_drugs
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAminoAcidDerivatives yago:Abstraction100002137 yago:Acetamide114711197 yago:Amide114724264 yago:Calculation105802185 yago:Chemical114806838 yago:Cognition100023271 yago:Compound114818238 yago:DerivedFunction106014730 yago:HigherCognitiveProcess105770664 yago:Material114580897 yago:Matter100020827 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:ProblemSolving105796750 yago:Process105701363 yago:PsychologicalFeature100023100 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thinking105770926 yago:WikicatAcetamides
rdfs:comment	Remacemide is a drug which acts as a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. Because remacemide has only a modest effect on seizure frequency and causes dizziness, it is no longer believed that remacemide will be an effective treatment for epilepsy. Although no such statement has been made about remacemide's potential for treating stroke, Huntington's, or Parkinson's, remacemide is no longer being developed for these conditions. (en)
rdfs:label	Remacemide (en)
owl:sameAs	freebase:Remacemide yago-res:Remacemide wikidata:Remacemide dbpedia-sh:Remacemide dbpedia-sr:Remacemide https://global.dbpedia.org/id/4u88U
prov:wasDerivedFrom	wikipedia-en:Remacemide?oldid=1117617699&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Remacemide.svg
foaf:isPrimaryTopicOf	wikipedia-en:Remacemide
is dbo:wikiPageWikiLink of	dbr:Delucemine dbr:Huntington's_disease dbr:Remacemide dbr:Ephenidine dbr:NPDPA dbr:MT-45 dbr:Budipine dbr:AD-1211 dbr:Fluorolintane dbr:Diphenidine dbr:C17H20N2O dbr:Orrin_Devinsky dbr:Cerebroprotectant dbr:NMDA_receptor_antagonist dbr:List_of_drugs:_Re
is foaf:primaryTopic of	wikipedia-en:Remacemide